Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 5/20 | 0.35 |
| ▸ | LIPG | Q9Y5X9 | 5/20 | 0.35 |
| ▸ | CNR1 | P21554 | 3/20 | 0.32 |
| ▸ | CNR2 | P34972 | 3/20 | 0.32 |
| ▸ | MMP2 | P08253 | 2/20 | 0.31 |
| ▸ | MMP9 | P14780 | 2/20 | 0.31 |
| ▸ | MMP8 | P22894 | 2/20 | 0.31 |
| ▸ | MMP13 | P45452 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14087192 | 1.00 | LPL (0.35) | LPLLIPGCNR1CNR2MMP2 | |
| SCHEMBL403451 | 1.00 | LPL (0.35) | LPLLIPGCNR1CNR2MMP2 | |
| SCHEMBL30015088 | 1.00 | LPL (0.35) | LPLLIPGCNR1CNR2MMP2 | |
| SCHEMBL14666214 | 1.00 | LPL (0.35) | LPLLIPGCNR1CNR2MMP2 | |
| SCHEMBL4262758 | 1.00 | LPL (0.35) | LPLLIPGCNR1CNR2MMP2 | |
| SCHEMBL12889892 | 0.97 | LPL (0.33) | LPLLIPGCNR1CNR2 | |
| SCHEMBL20169752 | 0.97 | LPL (0.33) | LPLLIPGCNR1CNR2 | |
| SCHEMBL793157 | 0.95 | LPL (0.33) | LPLLIPGCNR1CNR2 | |
| SCHEMBL17517833 | 0.95 | LPL (0.33) | LPLLIPGCNR1CNR2 | |
| SCHEMBL4262919 | 0.95 | LPL (0.33) | LPLLIPGCNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3792266-A1 | COMPOUND, METHOD FOR PRODUCING COMPOUND, AND METHOD FOR PRODUCING LIGHT-EMITTING MATERIAL USING SAME | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2021-03-17 | — | — | EP | disclosed |
| EP-2871198-B1 | METHOD FOR PRODUCING AROMATIC COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2017-06-14 | — | — | EP | disclosed |
| EP-2383306-B1 | META-PHENYLENE-BASED POLYMER AND LUMINESCENT ELEMENT FORMED USING SAME | SUMITOMO CHEMICAL CO (JP) | 2017-04-26 | — | — | EP | disclosed |
| US-9453103-B2 | Method for producing aromatic compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-09-27 | — | — | US | disclosed |
| US-9412950-B2 | Polymer compound and organic photoelectric conversion device | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-08-09 | — | — | US | disclosed |
| US-9412950-B2 | Polymer compound and organic photoelectric conversion device | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-08-09 | — | — | US | disclosed |
| US-9362515-B2 | Photoelectric conversion element | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-06-07 | — | — | US | disclosed |
| US-9362515-B2 | Photoelectric conversion element | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-06-07 | — | — | US | disclosed |
| US-9318719-B2 | Method of producing organic photoelectric conversion device | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-04-19 | — | — | US | disclosed |
| US-9318719-B2 | Method of producing organic photoelectric conversion device | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-04-19 | — | — | US | disclosed |
| US-20090066224-A1 | DICARBAZOLE AROMATIC AMINE POLYMERS AND ELECTRONIC DEVICES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-03-12 | — | — | US | disclosed |
| US-20090048413-A1 | Method for Production of Conjugated Polymer | SUMITOMO CHEMICAL COMPANY, LIMITED | 2009-02-19 | — | — | US | disclosed |
| EP-1576032-B1 | TRICYCLIC ARYLAMINE MONOMER AND POLYMERS AND DEVICES THEREOF | DOW GLOBAL TECHNOLOGIES INC (US) | 2007-10-17 | — | — | EP | disclosed |
| US-20070126345-A1 | Halogenated bisdiarylaminopolycylic aromatic compounds and polymers thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-06-07 | — | — | US | disclosed |
| US-20070102695-A1 | Crosslinkable substituted fluorene compounds and conjugated oligomers or polymers based thereon | DOW GLOBAL TECHNOLOGIES INC. | 2007-05-10 | — | — | US | disclosed |
| EP-1576032-A1 | TRICYCLIC ARYLAMINE MONOMER AND POLYMERS AND DEVICES THEREOF | Dow Global Technologies Inc. (US) | 2005-09-21 | — | — | EP | disclosed |
| US-6916902-B2 | Tricyclic arylamine containing polymers and electronic devices therefrom | DOW GLOBAL TECHNOLOGIES INC. (US) | 2005-07-12 | — | — | US | disclosed |
| WO-2005049546-A1 | HALOGENATED BISDIARYLAMINOPOLYCYLIC AROMATIC COMPOUNDS AND POLYMERS THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-06-02 | — | — | WO | disclosed |
| WO-2004060970-A1 | TRICYCLIC ARYLAMINE MONOMER AND POLYMERS AND DEVICES THEREOF | DOW GLOBAL TECHNOLOGIES INC. (US) | 2004-07-22 | — | — | WO | disclosed |
| US-20040127666-A1 | Tricyclic arylamine containing polymers and electronic devices therefrom | DEPARTMENT OF THE NAVY | 2004-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090066224-A1 | DICARBAZOLE AROMATIC AMINE POLYMERS AND ELECTRONIC DEVICES | NAT1, SAT1, RIF1 | LPL 4867/4885LIPG 4596/4885CNR1 389/4885 |
| US-20070102695-A1 | Crosslinkable substituted fluorene compounds and conjugated oligomers or polymers based thereon | THEM6, PCNA, PARG | LPL 3904/4885LIPG 2150/4885CNR1 4760/4885 |
| US-20070126345-A1 | Halogenated bisdiarylaminopolycylic aromatic compounds and polymers thereof | AHR, AADAC, ARNT | LPL 1503/4885LIPG 3460/4885CNR1 920/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.